发明申请
US20060252759A1 New tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity
失效
新的四环六氮嗪基吲哚啉作为肥胖的5HT2C受体激动剂
- 专利标题： New tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity
- 专利标题（中）： 新的四环六氮嗪基吲哚啉作为肥胖的5HT2C受体激动剂
-
申请号： US11412501申请日： 2006-04-26
-
公开(公告)号： US20060252759A1公开(公告)日： 2006-11-09
- 发明人: Paul Hebeisen , Nathaniel Monck , Hans Richter , Stephan Roever
- 申请人： Paul Hebeisen , Nathaniel Monck , Hans Richter , Stephan Roever
- 优先权： EP05103703.4 20050503
- 主分类号： C07D498/22
- IPC分类号： C07D498/22 ; C07D491/22 ; A61K31/498
摘要：
The present invention refers to chemical compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5 have the significance given in claim 1. These compounds can be used for the preparation of medicaments.
公开/授权文献
信息查询
